Boehringer Ingelheim Corporation Release: New Pradaxa® Data To Be Presented During The American College of Cardiology’s 63rd Annual Scientific Session

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Boehringer Ingelheim has today announced that new findings from ongoing Pradaxa® (dabigatran etexilate) research will be presented during the American College of Cardiology’s 63rd Annual Scientific Session (ACC.14) in Washington, USA, 29 – 31 March 2014. The data form part of Boehringer Ingelheim’s ongoing commitment to scientific innovation and advancing patient care.

Help employers find you! Check out all the jobs and post your resume.

Back to news